Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Miglustat (Primary)
- Indications Gangliosidoses; Tay-Sachs disease
- Focus Therapeutic Use
- Acronyms Syner-G
- 03 Dec 2014 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019 according to ClinicalTrials.gov record.
- 03 Dec 2014 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019 according to ClinicalTrials.gov record.
- 06 Mar 2014 Status changed from not yet recruiting to recruiting.